Uncategorized

Clinical trial reveals twice-yearly injection reduces risk of HIV infection by 96% – Medical Xpress

  1. Clinical trial reveals twice-yearly injection reduces risk of HIV infection by 96%  Medical Xpress
  2. Gilead Sciences: Designing Inclusive Clinical Trials in an Effort To Upend the HIV Epidemic  CSRwire.com
  3. Gilead’s Scientific Innovation at the Forefront of Helping End the HIV Epidemic  Gilead Sciences
  4. ‘Huge relief’ as new drug found to effectively prevent HIV infection  Yahoo! Voices
  5. Lead Gilead researcher highlights need for inclusive clinical trials for HIV  Clinical Trials Arena